Background: Persistent postoperative pain is a major health problem affecting nearly 30% of all patients undergoing total hip arthroplasty. Previous studies have demonstrated an association between the intensity of acute postoperative pain and persistent pain, but this association might be an epiphenomenon of insufficient intraoperative analgesia. In this study, we investigated the association between the intraoperative level of analgesia and the persistent postoperative pain 6 months after surgery. Methods: We investigated 110 patients undergoing primary total hip arthroplasty under total intravenous general anaesthesia in a prospective cohort study. A highly standardized surgical and a standardized anaesthetic procedure were performed to reduce variability and psychosocial influences were investigated to adjust for confounders. Acute postoperative pain was controlled using patient-controlled analgesia pumps. Postoperative pain intensities and analgesic requirements were monitored for 6 months following surgery. Results: Of 105 patients included in the analysis, 32% continued using daily pain medication 6 months after surgery and reported a median pain level of 4/10. Multivariate analyses confirmed that the amount of intraoperative analgesia is a significant predictor of regular analgesic use and pain intensity 6 months after surgery. Conclusions: Higher levels of intraoperative analgesia are associated with lower levels of persistent pain and less analgesic consumption 6 months after total hip arthroplasty. Persistent pain may be attributable to intraoperative nociception, which is likely not adequately assessed and suppressed using current clinical measures. Significance: Our study suggests that lower doses of intraoperative analgesia are associated with higher levels of persistent postoperative pain. Persistent pain may be caused by intraoperative nociception, which is likely not adequately suppressed using current clinical standard analgesic measures.
Introduction
Persistent postoperative pain lasting for more than 3-6 months after a surgical intervention is a largely unrecognized major health problem. Persistent pain can affect up to 50% of patients depending on the surgical procedure . For instance upwards of 30% of patients that underwent total hip arthroplasty, a common elective procedure, reported persistent pain 12-18 months postoperatively (Nikolajsen et al., 2006) .
Arthroplasty patients are an interesting focus group when studying pain chronification and treatment strategies, because arthroplasty (1) is a common surgical procedure, (2) has a high rate of persistent postoperative pain and (3) induces a relatively small amount of direct nerve damage intraoperatively in comparison with other procedures attributed with high rates of persistent postoperative pain (Unwin and Scott, 1999; Pinto et al., 2013) . Therefore, pain chronification in arthroplasty patients may be the direct result of excessive nociceptive input without the additional complexity of neuropathic pain components Nikolajsen et al., 2006) .
The current understanding is that persistent postoperative pain may develop due to excessive nociceptive input . The theory is that intense noxious peripheral stimuli induce synaptic hyperplasticity in the spinal cord, called central sensitization, which increases the responsiveness of nociception processing neurons . The clinical correlate of this mechanism has been shown in that acute postoperative pain intensity was repeatedly associated with chronic pain development (Katz et al., 1996; Tasmuth et al., 1996; Callesen et al., 1999) .
Previous clinical studies have focused on the postoperative phase of pain management and shown that a lack of postoperative pain suppression leads to pain chronification . Intraoperative nociception has, to the best of our knowledge, not yet been taken into account, but may also lead to pain chronification through central sensitization when met with insufficient intraoperative analgesia . Currently, it is standard clinical practice to base analgesia dosages intraoperatively on clinical signs -e.g. patient movement, heart rate or blood pressure elevation. However, clinical signs have limited sensitivity to detect nociception and phases where central sensitization may occur (von Dincklage, 2015) . Therefore, patients receiving general anaesthesia following clinical standard analgesic dosing practice -i.e. to prevent clinical signs of nociception -might undergo intraoperative central sensitization and be susceptible to pain chronification despite having shown no clinical signs of nociception. Increased intraoperative analgesic dosages may effectively prevent central sensitization, as observed in the early postoperative phase. Our hypothesis is, therefore, that higher doses of intraoperative analgesia in patients undergoing general anaesthesia are associated with lower levels of persistent pain and less analgesic consumption 6 months following total hip arthroplasty.
To determine whether intraoperative analgesia levels associate with postoperative pain chronification, we performed a secondary analysis of data gained during a prospective cohort study.
Methods

Ethics
Ethics approval for this study (Number EA1/033/13) was provided by the Ethical Committee of Charit e, Berlin, Germany (Chairperson Professor R. Uebelhack) on 4 April 2013.
Outline of the study and patient inclusion
We conducted this prospective cohort study in patients undergoing total hip arthroplasty under general anaesthesia. The study was performed primarily to investigate the predictability of immediate postoperative pain by intraoperative nociceptive reflexes (Jakuscheit et al., 2017) . Here, the reported secondary objective of the study was to assess the relationship between acute and chronic pain. Of 171 patients that were assessed for eligibility for participation in the study, 122 patients were included for the evaluation of this secondary aim (Fig. 1) . Here we describe only the methodology relevant for this secondary aim of the study. Before patient inclusion, we registered the study at the German clinical trial register (Deutsches Register Klinischer Studien, Freiburg, Germany; registration number DRKS00000665). Patients were recruited during the preoperative consultation. To be eligible for inclusion into this study, patients had to be scheduled for a primary hip replacement surgery under general anaesthesia and be over the age of 18 years. Patients were excluded if they had an ASA health status >3, a BMI >35 and any regional, epidural or spinal anaesthesia.
After providing written informed consent for participation, the patients underwent a preoperative interview where they provided information regarding their current pain status, pain medication use and completed a variety of psychological questionnaires regarding factors that might influence pain chronification. We collected analgesic consumption and pain intensity data intraoperatively and during the first seven postoperative days. Follow-up was performed 6 months after surgery using questionnaires to assess current pain status and use of analgesics.
Preoperative interview
At the preoperative interview we asked patients to rate their average current overall pain intensity on a numerical rating scale ranging from 0 to 10 (Jensen et al., 1986; Dworkin et al., 2008) , questioned them about pain location and whether they were currently taking regular daily pain medication. In addition, we recorded biometric data, history of alcohol and tobacco use and ASA health classification and diabetic status.
To investigate psychological factors that might influence pain perception and pain chronification, we asked patients to complete a variety of validated questionnaires in their German versions. To capture signs of anxiety, we performed the state-trait anxiety inventory (STAI; Julian, 2011) and the hospital anxiety and depression scale (HADS; Zigmond and Snaith, 1983) , which also assesses signs of depression. Pain sensitivity was quantified using the pain sensitivity questionnaire (PSQ; Ruscheweyh et al., 2009 ) and pain catastrophizing was measured using the pain catastrophizing scale (PCS; Sullivan et al., 1995) .
Surgical and anaesthetic procedure
All patients underwent primary hip replacement surgery through the lateral transgluteal approach (Bauer and Russe, 1984) , for which they received a general anaesthesia that was performed using propofol and remifentanil, supplemented by piritramide and metamizole towards the end of the surgery to prevent early postoperative pain. Dosing of all drugs was left to the clinical judgement of the respective staff anaesthesiologist, who was not involved in the study and not informed about the exact nature of the study. As possible influences on postoperative pain, we recorded the duration of surgery as well as the administered doses of propofol, remifentanil, piritramide and metamizole.
Postoperative assessment
To track the development of acute and persistent postoperative pain we regularly assessed the patients' pain status and analgesic consumption. Directly after the patients regained consciousness, we questioned them for their immediate postoperative pain intensity on the same numerical rating scale used during the preoperative assessment and provided them with an intravenous patient-controlled analgesic (PCA) pump, through which they were able to receive boli of 2 mg piritramide every 5 min. We then assessed the pain intensity at 1 h following surgery (current pain at that moment), 24 h after surgery (average pain level on that day) and 7 days after surgery (average pain level on that day). Accordingly, we recorded the piritramide consumption during the first hour and the first 24 h, as well as the duration until the PCA pump was discontinued. PCA pump discontinuation was decided by the patients after a minimum duration of 24 h and a maximum limit of 72 h. Furthermore, we recorded whether patients were taking a regular daily pain medication on day 7 after surgery and the overall length of hospital stay after surgery. After hospital discharge, we contacted the patients 6 months after surgery and again assessed current subjective pain intensity (average pain level on that day) and analgesic use.
Statistical analysis
Statistical analyses were performed for two outcome variables that both measure persistent postoperative pain: the actual pain intensity and the analgesic use (yes/no) at 6 months after surgery. To investigate possible influences on these outcome variables, we calculated univariate Spearman's correlations with a variety of pre-, intra-and postoperative factors, including the postoperative pain intensities immediately, 1 h, 1 day and 1 week after surgery, as well as two parameters quantifying intraoperative analgesia: the intraoperative average remifentanil dose and the intraoperative piritramide dose.
To analyse whether the parameters identified in the univariate correlations as predictor variables remain significant in the presence of other predictor variables, we calculated a multivariate logistic regression analysis to predict analgesic use 6 months after surgery and a multivariate linear regression analysis to predict the pain intensity 6 months after surgery. For both multivariate analyses, we included all pre-, intra-and postoperative influences investigated in the univariate analyses as predictor variables.
As we here report only secondary results of a study designed for a different primary research question (Jakuscheit et al., 2017) , the sample size calculations do not apply to the reported outcome variables. Therefore the statistical analysis reported here should be regarded as explorative.
All statistical testing and modelling was performed using SPSS Statistics 23 (IBM Corporation, Armonk, USA).
Results
Of the 122 patients included in this investigation, 5 were excluded due to missing perioperative data and 12 were lost to follow-up (Fig. 1) . Of the remaining 105 patients, 32% were still taking pain medication on a regular basis and reported a median pain intensity of 4 (3-5) [median (IQR)] 6 months after surgery. The characteristics of the complete population are shown in Table 1 . 105 10 (9-12) Postoperative regular pain medication (no/yes) 6 months after surgery 68/37 Postoperative pain intensity (0-10) 6 months after surgery 105 2 (1-5) Postoperative pain intensity (NRS = 0/1/2) 6 months after surgery 24/10/19 Postoperative pain intensity (NRS = 3/4/5) 6 months after surgery 14/11/13 Postoperative pain intensity (NRS = 6/7/8/9/10) 6 months after surgery 5/4/2/2/1
Univariate analyses showed that the two outcome parameters, regular analgesic use and pain intensity at 6 months after the surgery, did not correlate with immediate postoperative pain intensity, acute postoperative pain or analgesic consumption 1 h after surgery (Table 2) .
Intraoperative analgesia -i.e. average intraoperative remifentanil rate and intraoperative piritramide dose -showed strong correlations with daily pain medication use and pain intensity at 6 months postoperatively (Fig. 2) .
Multivariate logistic regression analysis revealed the following factors as predictors of regular analgesic use 6 months after surgery: preoperative regular pain medication (p < 0.001), intraoperative average remifentanil rate (p < 0.001), pain catastrophizing (PCS) (p < 0.01), 1 h postoperative pain intensity (p < 0.01) and lower HADS depression scale values (p < 0.05) ( Table 3 ). In addition, the following factors were identified as predictors for pain intensity 6 months after the surgery by multivariate linear regression analysis: preoperative pain intensity (p < 0.05), anxiety trait (STAI; p < 0.01), intraoperative piritramide dose (p < 0.05) and lower HADS depression scale values (p < 0.05) ( Table 3) . The table shows the univariate Spearman's correlation coefficients of regular pain medication and pain intensity at 6 months after surgery with a variety of pre-, intra-and postoperative factors. Significant correlations are highlighted in bold font and marked with asterisks (*p < 0.05; **p < 0.01; ***p < 0.001). Statistical significances are based on the shown p-values without multiple comparison corrections to visualize relations within the data to identify possible confounders. Performing Bonferroni's multiple comparison correction for 60 multiple comparisons (all 30 pre-, intra-and postoperative factors for each of the two outcome variables) would reduce the threshold for significance from p < 0.05 to p < 0.00083, at which only the preoperative regular pain medication and the intraoperative average remifentanil rate remain as significant correlations with the regular pain medication at 6 months after surgery and only the intraoperative piritramide dose remains as significant correlation with the pain intensity at 6 months after surgery.
Discussion
The primary finding of this study was that higher levels of intraoperative analgesia are associated with lower levels of persistent pain and pain medication usage 6 months after total hip arthroplasty. Intraoperative analgesia was quantified here using both the average intraoperative remifentanil administration rate and the intraoperative piritramide dose. The intraoperative remifentanil administration rate was a direct quantitative measure of continuous intraoperative analgesia. Piritramide, on the other hand, was administered near the end of the surgical procedure to prevent postoperative pain (like morphine in other countries). However, we observed that piritramide was administered a median of 50 (IQR: 36-67) minutes prior to extubation -meaning that its main effect was likely exerted intraoperatively rather than postoperatively. The results presented here are based on a secondary analysis of a prospective cohort trial that was not designed to assess the relationship between intraoperative analgesia and persistent postoperative pain. Therefore, our findings must be interpreted carefully. Specifically, because we performed several multiple comparisons, it is possible that the associations reported here arose from chance. However, the p-values observed in univariate correlations were robust and remained so after adjusting for multiple comparisons. Moreover, the raw data face validity confirms continuous data structures (Fig. 2) . In addition, both intraoperative analgesics (remifentanil and piritramide) showed significant univariate correlations with both outcome measures for persistent pain, supporting that the associations reported here are likely not merely the result of chance (Table 2) . Finally and most important, multivariate analyses showed that intraoperative analgesics independently associated with persistent pain and long-term postoperative pain medication use (Table 3) . If univariate correlations were due to chance, the underlying factors should correlate equally with all other confounders and therefore not show a significant independent association in the overall multivariate model. Our analyses showed that though the two intraoperative analgesics correlated with each other, they remained independently associated with persistent postoperative pain in the presence of all other covariates. Therefore, we consider the results presented herein to have a high level of internal validity.
Our findings augment those of several studies that have shown that both preoperative pain and acute postoperative pain are correlated with persistent postoperative pain (Katz et al., 1996; Tasmuth et al., 1996; Callesen et al., 1999; Ip et al., 2009 ). To date, no studies have been performed that specifically assess the relationship between intraoperative nociception/analgesia and persistent postoperative pain. It seems likely that intraoperative nociception (like preoperative and acute postoperative pain) leads to persistent postoperative pain vis-a-vis the central sensitization model -i.e. painful stimuli induce synaptic hyperplasticity which leads to pain chronification . Our data indicate that preexisting pain, acute postoperative pain and intraoperative nociception can lead to long-lasting changes in nociceptive processing.
Regarding the external validity, our results are likely representative of patients undergoing general The table shows all parameters that showed significant influences on regular pain medication and pain intensity at 6 months after surgery in the multivariate regression models. All pre-, intra-and postoperative factors described in Tables 1 and 2 were included in the multivariate models as possible predictor variables. The level of significance of each parameter is marked with asterisks (*p < 0.05; **p < 0.01; ***p < 0.001). To describe the overall accuracy of the logistic regression model to predict regular pain medication at 6 months after surgery, the overall model accuracy is shown in the last column of (A).
To describe the overall accuracy of the linear regression model to predict pain intensity at 6 months after surgery, the overall model correlation coefficient R is shown in the last column of (B).
anaesthesia for primary arthroplasty, as our inclusion and exclusion criteria were non-restrictive. These results may not be transferable, however, to patients undergoing other surgical procedures. Surgeries that are known to induce more nerve damage than arthroplasty likely induce additional neuropathic pain and may therefore have a different underlying pathophysiological mechanism leading to pain chronification . Nevertheless, the central sensitization mechanism likely plays a role in all postoperative pain patients (concomitantly with neuropathic pain mechanisms) and therefore our results might be generalizable, at least to some extent, to all surgical patients. However, even if the association between higher intraoperative analgesia and lower levels of persistent pain seems both internally and externally valid, it remains unclear as to whether higher doses of analgesia improve patient outcomes, as, for example, high intraoperative opiate doses may induce hyperalgesia in some patients. Further interventional studies are needed to address this issue. Our data additionally confirm previous findings that psychosocial factors -including pain sensitivity, pain catastrophizing and anxiety -associate with pain chronification.
Limitations
This study has several limitations. First, because this was a secondary analysis of a prospective cohort trial, it was not specifically designed to assess the relationship between intraoperative analgesia and persistent postoperative pain. Therefore, the level of validity that can be achieved in this study is limited.
Second, due to the primary objective of the trial, general anaesthesia was not performed in a highly standardized fashion -rather, analgesic dosages were Figure 2 Association between intraoperative analgesia and persistent postoperative pain and analgesic use 6 months after surgery. The figure shows the association of the intraoperative remifentanil rate with (A) the pain intensity and (B) analgesic use at 6 months after surgery. Also shown are the associations of the intraoperative piritramide dose with (C) the pain intensity and (D) analgesic use at 6 months after surgery. Dots and error bars represent means and standard errors of the means. Increasing variability at higher pain scores is due to lower numbers of patients that exhibited these pain levels (see Table 2 ).
left to the discretion of the clinical anaesthesiologist and thus represent 'clinical routine'. This means that there was a certain level of variation in intraoperative analgesic administration and possibly patient nociception, as there is in clinical routine. Because of this variability in intraoperative pain levels, it is possible that the original power and sample size estimations were insufficient to assess our hypothesis. However, based on the robustness of our findings, we do not believe that this sub-study was underpowered.
Third, the follow-up assessment of the outcome measures was performed using a questionnaire, which may have predisposed for a selection bias. However, the questionnaire return rate was over 90%.
Implications for the intraoperative dosing of analgesics
Our results indicate that persistent postoperative pain can at least partly be induced by excessive intraoperative nociception that is not suppressed using routine clinical analgesic practices. Therefore, it is likely that the current standards for intraoperative analgesia dosing need to be modified. Currently, intraoperative analgesia is dosed according to clinical nociception signs -e.g. intraoperative patient movement, heart rate and/or blood pressure elevation, tearing and sweating in response to painful stimuli (Guignard, 2006; . However, with the exception of movement, all other clinical responses have a low specificity for nociception because their primary physiological functions are not necessarily intended as a response to nociception, but rather as regulatory mechanisms of specific physiological systems. Moreover, the sensitivity of these clinical signs as nociception surrogates remains unknown. This is because, to date, there is no standardized, valid and comprehensive method to assess nociception. Therefore, movement responses to painful stimuli are currently used as the de facto 'gold standard' surrogate for nociception, though the sensitivity remains completely unknown.
As our results suggest that higher doses of analgesics are associated with less persistent pain in patients which received analgesic dosing based on clinical responses, the most probable explanation following the law of parsimony is that clinical responses are not sufficiently sensitive for the measurement of intraoperative nociception.
However, this problem cannot be met by arbitrarily increasing intraoperative dosing of opioids, as higher opioid doses might also induce negative effects on patients outcome, especially due to their potential to trigger hyperalgesia (Kim et al., 2014; Yu et al., 2016) and dose-dependent side effects like nausea/vomiting (Apfel et al., 2012) , apnoea and prolonged emergence times (Macintyre et al., 2011) . Therefore, the goal can neither be to generally advocate the use of higher doses of opioids to prevent postoperative pain nor to generally avoid higher doses of opioids in fear of side effects or hyperalgesia. Instead, a better goal might be to develop tools to assess patient nociception. If a patient's individual nociception level could continuously be assessed throughout general anaesthesia, analgesic dosages could be titrated accordingly (i.e. patient and stimuli dependent).
Currently, a variety of different tools to measure intraoperative nociception and/or analgesia are under investigation in clinical studies. These are based on a wide range of physiological mechanisms including skin conductance (Storm, 2008) , haemodynamics (Wennervirta et al., 2008; Rossi et al., 2012; Gruenewald et al., , 2015 , electroencephalogram (Haenggi et al., 2008; Sahinovic et al., 2014) and a variety of nociceptive reflexes (von Dincklage et al., 2009 (von Dincklage et al., , 2010 (von Dincklage et al., , 2012 Paulus et al., 2013; Guglielminotti et al., 2015; Ly-Liu and ReinosoBarbero, 2015; Jakuscheit et al., 2017) . Currently, however, none of the tools have been shown to have enough specificity/sensitivity to outweigh the effort and cost of their routine clinical application von Dincklage, 2015) .
Summary
Our results indicate that higher levels of intraoperative analgesia are associated with lower levels of persistent pain and lower risk of analgesic use 6 months after total hip arthroplasty. Our analyses show that this association seems to be significant even in the presence of the known confounders of pain chronification, e.g. psychosocial factors. It is possible that persistent postoperative pain arises from intraoperative nociception despite general anaesthesia performed in accordance with current clinical standards.
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